Patent Applications published on Sep 11, 2025 - page 3

#601
US20250281348A1
Human necessities

ADULT TOY AND RELATED NETWORK AND SERVICE-BASED INTERACTION

#602
US20250281349A1
Human necessities

WEARABLE DEVICE FOR VIBRATORY STIMULATION AND METHODS OF USE

#603
US20250281350A1
Human necessities

VIBROACOUSTIC DEVICES, SYSTEMS, AND METHODS FOR PROMOTING REST

#604
US20250281351A1
Human necessities

HEAD-MOUNTED CLAMPING-TYPE HEAD MASSAGE DEVICE

#605
US20250281352A1
Human necessities

MULTIFUNCTIONAL WAIST PHYSIOTHERAPY INSTRUMENT

#606
US20250281353A1
Human necessities

FOOT MASSAGER

#607
US20250281354A1
Human necessities

Pressure Pad Headgear Device

#608
US20250281355A1
Human necessities

NFC-ENABLED MEDICAL DEVICE SYSTEM AND PROCESSES FOR GENERATING ASSOCIATED INFORMATION LAYER

#609
US20250281356A1
Human necessities

GLASS CONTAINERS FOR PACKAGING SALT OR SUGAR-CONTAINING COMPOSITIONS IN A FROZEN STATE

#610
US20250281357A1
Human necessities

CONTAINER WITH THREADED CONNECTOR

#611
US20250281358A1
Human necessities

VIAL HOLDER

#612
US20250281359A1
Human necessities

INSTALLATION FOR PRODUCING A MEDICAL PREPARATION

#613
US20250281360A1
Human necessities

KEYED MEDICATION CARTRIDGE FOR USE IN A HANDHELD ORAL MEDICATION DISPENSING DEVICE

#614
US20250281361A1
Human necessities

MEDICATION DISPENSING SYSTEM HAVING A HANDHELD ORAL MEDICATION DISPENSING DEVICE WITH KEYED MEDICATION CARTRIDGE

#615
US20250281362A1
Human necessities

SINGLE-USE MULTI-COMPARTMENT BABY FORMULA POUCH

#616
US20250281363A1
Human necessities

DENTAL COMPOSITION

#617
US20250281364A1
Human necessities

MULTILAYER DISSOLVABLE SOLID ARTICLE CONTAINING COATING COMPOSITION AND PROCESS FOR MAKING THE SAME

#618
US20250281365A1
Human necessities

SOLID COSMETIC CARE COMPOSITION COMPRISING AT LEAST ONE CAVITY

#619
US20250281366A1
Human necessities

SOLID COSMETIC COMPOSITION COMPRISING AT LEAST ONE CAVITY

#620
US20250281367A1
Human necessities

HYDROGEN PEROXIDE TEETH WHITENING GEL

#621
US20250281368A1
Human necessities

HAIR CONDITIONING COMPOSITION

#622
US20250281369A1
Human necessities

Calming Sunscreen Body Butter

#623
US20250281370A1
Human necessities

AQUEOUS LIQUID COSMETIC

#624
US20250281371A1
Human necessities

PLANT PROTEIN-BASED MICROCAPSULES

#625
US20250281372A1
Human necessities

POWDERS HAVING IMPROVED DISPERSABILITY AND USE THEREOF IN COMPOSITIONS AND ARTICLES OF MANUFACTURE

#626
US20250281373A1
Human necessities

POWDER AND LIQUID COMPOSITIONS FOR DENTAL CARE, AND METHODS OF USE THEREOF

#627
US20250281374A1
Human necessities

Dentifrice Compositions Comprising Tin Ions

#628
US20250281375A1
Human necessities

NON-AQUEOUS DENTIFRICE COMPOSITION

#629
US20250281376A1
Human necessities

Hair Care Composition

#630
US20250281377A1
Human necessities

TOPICAL HYDRATION COMPOSITIONS

#631
US20250281378A1
Human necessities

PEPTIDE HAVING ACTIVITY OF PREVENTING HAIR LOSS OR PROMOTING HAIR GROWTH AND USE THEREOF

#632
US20250281379A1
Human necessities

Cosmetic and Personal Care compositions

#633
US20250281380A1
Human necessities

Skincare Formulation for Multi-Modal Reduction of Acetylcholine Concentration and Activity

#634
US20250281381A1
Human necessities

TOPICAL COMPOSITIONS AND METHODS

#635
US20250281382A1
Human necessities

OIL-BASED COSMETIC

#636
US20250281383A1
Human necessities

NON-THERAPEUTIC USE OF HYPERBRANCHED DEXTRINS AS A SOOTHING AGENT

#637
US20250281384A1
Human necessities

POLYESTER, VISCOUS MIXTURE, PROCESS FOR PREPARING SAME AND COSMETIC COMPOSITION

#638
US20250281385A1
Human necessities

FOAMING MIXED ALCOHOL/WATER COMPOSITIONS COMPRISING A COMBINATION OF ALKYL SILOXANE AND A HYDROTROPE/SOLUBILIZER

#639
US20250281386A1
Human necessities

SURFACTANT COMPOSITION AND COSMETIC

#640
US20250281387A1
Human necessities

NATURAL COSMETIC PROCESS AND COMPOSITION

#641
US20250281388A1
Human necessities

COMPOSITIONS COMPRISING BREVIBACILLA MULTIFUNCTIONAL FERMENTATES AND METHODS OF USE

#642
US20250281389A1
Human necessities

AMMONIA OXIDIZING MICROORGANISMS FOR PH MODULATION

#643
US20250281390A1
Human necessities

OSMOTIC PUMP TABLET, PREPARATION METHOD THEREFOR AND USE THEREOF

#644
US20250281391A1
Human necessities

EFFERVESCENT COMPOSITION AND METHOD FOR DETERMINING BITTERNESS PERCEPTION

#645
US20250281392A1
Human necessities

TOPICAL DELIVERY OF EPINEPHRINE AND PRODRUG COMPOSITIONS

#646
US20250281393A1
Human necessities

BODY CAVITY GEL

#647
US20250281394A1
Human necessities

ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS

#648
US20250281395A1
Human necessities

OPHTHALMIC PREPARATION FOR TREATING MACULAR EDEMA, OPTIC NEURITIS AND NON-INFECTIOUS ENDOPHTHALMITIS THROUGH EYE DROP ADMINISTRATION

#649
US20250281396A1
Human necessities

METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION

#650
US20250281397A1
Human necessities

FORMULATIONS OF A PLASMA KALLIKREIN INHIBITOR

#651
US20250281398A1
Human necessities

ORAL RECEPTACLE

#652
US20250281399A1
Human necessities

A MUCOADHESIVE FILM COMPRISING A PHARMACEUTICALLY ACTIVE AGENT AND USES THEREOF

#653
US20250281400A1
Human necessities

Pharmaceutical Formulation

#654
US20250281401A1
Human necessities

DEVICES AND METHODS FOR DELIVERY OF SUBSTANCES TO ANIMALS

#655
US20250281402A1
Human necessities

COMPOSITIONS FOR LOCAL THERAPY DELIVERY TO BRAIN TUMORS AND METHODS

#656
US20250281403A1
Human necessities

FORMULATIONS

#657
US20250281404A1
Human necessities

COMPOSITION FOR USE IN PRESSURISED DISPENSING CONTAINER

#658
US20250281405A1
Human necessities

POLYMERSOMES COMPRISING A SOLUBLE ENCAPSULATED POLYNUCLEOTIDE AND AN IONIZABLE LIPID AS WELL AS METHODS OF MAKING AND USES THEREOF

#659
US20250281406A1
Human necessities

COMPOUNDS, COMPOSITIONS AND METHODS FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS

#660
US20250281407A1
Human necessities

LIPID DEPOT FORMULATIONS

#661
US20250281408A1
Human necessities

AMORPHOUS SOLID DISPERSIONS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME

#662
US20250281409A1
Human necessities

CANNABINOIDAL COMPOSITIONS AND METHODS OF PRODUCING THE SAME

#663
US20250281410A1
Human necessities

HIGH-THROUGHPUT PREPARATION OF MICROPARTICLES WITH PULSATILE RELEASE

#664
US20250281411A1
Human necessities

TARGET-SPECIFIC THROMBOLYTIC UROKINASE MICROSPHERES AND METHOD TO DISSOLVE SICKLE DISEASE CLOTS

#665
US20250281412A1
Human necessities

Pharmaceutical formulations comprising tenofovir alafenamide and emtricitabine

#666
US20250281413A1
Human necessities

PHARMACEUTICAL COMPOSITION

#667
US20250281414A1
Human necessities

HIGH DOSE ENDOXIFEN FORMULATIONS AND METHODS OF USE

#668
US20250281415A1
Human necessities

EXOSOMES EXPRESSING RSVF AND USE THEREOF

#669
US20250281416A1
Human necessities

COATED NANOPARTICLE AGGREGATES COMPOSED OF A HYDROLYZED METAL SALT AND METHODS OF USE THEREOF

#670
US20250281417A1
Human necessities

MESOPOROUS SILICA NANOPARTICLES WITH LIPID BILAYER COATING FOR CARGO DELIVERY

#671
US20250281418A1
Human necessities

LIPID NANOPARTICLE FORMULATIONS AND METHODS OF SYNTHESIS THEREOF

#672
US20250281419A1
Human necessities

LIPID AMINES

#673
US20250281420A1
Human necessities

MACROPHAGE IMMUNOTHERAPY

#674
US20250281421A1
Human necessities

COMPOSITIONS FOR SUPPLEMENTING PRODUCTS WITH THERAPEUTIC AGENTS AND METHODS OF USE THEREOF

#675
US20250281422A1
Human necessities

CATIONIC LIPIDS CONTAINING SILICON

#676
US20250281423A1
Human necessities

VESICLES AND USES THEREOF

#677
US20250281424A1
Human necessities

SMALL MOLECULE ANTAGONISTS OF PF4

#678
US20250281425A1
Human necessities

METHODS FOR TREATING SKIN DISORDERS WITH A TOPICAL COMPOSITION OF BIS-(2-CHLOROETHYL)METHYLAMINE

#679
US20250281426A1
Human necessities

R-KETAMINE LIQUID PREPARATION AND USE THEREOF

#680
US20250281427A1
Human necessities

METHODS FOR TREATING NEURODEVELOPMENTAL DISORDERS VIA ADMINISTRATION OF ORGANIC TRICYCLIC COMPOUNDS

#681
US20250281428A1
Human necessities

Method Of Treating Major Depressive Disorder

#682
US20250281429A1
Human necessities

Novel Treatment Method for Painful Musculoskeletal Conditions

#683
US20250281430A1
Human necessities

BUPROPION AS A MODULATOR OF DRUG ACTIVITY

#684
US20250281431A1
Human necessities

Topical Antimicrobial Lotion for Treating Pyotraumatic Dermatitis Lesions

#685
US20250281432A1
Human necessities

KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATING OR PREVENTING OCULAR PAIN

#686
US20250281433A1
Human necessities

NOVEL DERIVATIVE COMPOUND HAVING BIPHENYL GROUP INTRODUCED INTO AMINO-ALKANOIC ACID AND ANTI-INFLAMMATORY COMPOSITION COMPRISING SAME

#687
US20250281434A1
Human necessities

OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

#688
US20250281435A1
Human necessities

CHEWABLE GUMMY CONTAINING BETA-HYDROXY BETA-METHYLBUTYRIC ACID (HMB)

#689
US20250281436A1
Human necessities

LUBRICANT

#690
US20250281437A1
Human necessities

METHODS OF TREATMENT OF CHOLESTATIC DISEASES

#691
US20250281438A1
Human necessities

COMPOSITIONS AND METHODS USING AT LEAST ONE GLYCINE OR DERIVATIVE THEREOF AND/OR AT LEAST ONE N-ACETYLCYSTEINE OR DERIVATIVE THEREOF, AND AT LEAST ONE THYMOL AND/OR CARVACROL

#692
US20250281439A1
Human necessities

USE OF L-ASPARTIC ACID BETA-HYDROXAMATE (L-ABH) IN PREPARATION OF DRUG FOR DIABETIC RETINOPATHY (DR) OR RETINOPATHY OF PREMATURITY (ROP)

#693
US20250281440A1
Human necessities

METHOD TO IMPROVE GROWTH PERFORMANCE, LIVABILITY, CARCASS CHARACTERISTICS AND/OR MILK QUALITY IN SWINE

#694
US20250281441A1
Human necessities

ORODISPERSIVE DOSAGE FORMS CONTAINING DROXIDOPA

#695
US20250281442A1
Human necessities

COMPOSITIONS COMPRISING 15-HEPE AND METHODS OF USING THE SAME

#696
US20250281443A1
Human necessities

OIL-IN-WATER EMULSIONS AND USES THEREOF IN RESISTING INFANTILE ECZEMA

#697
US20250281444A1
Human necessities

COMPOUND WITH NEW SKELETON OF URSANE TRITERPENOID - ENT-KAURANE DITERPENOID DIMER, AND PREPARATION METHOD THEREOF AND APPLICATION THEREOF

#698
US20250281445A1
Human necessities

Method of dietary treatment for genetic and epigenetic diseases and disorders

#699
US20250281446A1
Human necessities

COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER IN STANDARD OF CARE AND/OR PROFIBROTIC CHEMOTHERAPEUTIC AGENT-NAÏVE PATIENTS USING TUMOR TREATING FIELDS AND CHEMOTHERAPEUTIC AGENTS

#700
US20250281447A1
Human necessities

SIGMA-1 RECEPTOR AGONIST SYSTOLIC BLOOD PRESSURE THERAPY

#701
US20250281448A1
Human necessities

Cardioversion Methods Using Budiodarone

#702
US20250281449A1
Human necessities

NITROGEN-CONTAINING ANALOGS OF SALINOMYCIN FOR USE IN MULTIPLE MYELOMA (MM)

#703
US20250281450A1
Human necessities

PEPTIDE PHARMACEUTICALS FOR TREATMENT OF NASH AND OTHER DISORDERS

#704
US20250281451A1
Human necessities

COMPOSITIONS AND METHODS FOR MODULATING SLEEP AND USES THEREOF

#705
US20250281452A1
Human necessities

CHIRAL ARYL PROPIONIC ACID DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREOF, AND USE

#706
US20250281453A1
Human necessities

COMBINATION THERAPIES COMPRISING QTX125

#707
US20250281454A1
Human necessities

METHODS OF IMPROVING RENAL FUNCTION

#708
US20250281455A1
Human necessities

COMPOSITIONS AND METHODS FOR NEUROABLATION

#709
US20250281456A1
Human necessities

METHODS OF TREATING CANCER BY INHIBITING BACTERIAL DNAK TO RESTORE ACTIVITIES OF ANTICANCER DRUGS

#710
US20250281457A1
Human necessities

TREATMENT OR PREVENTION OF DENGUE VIRAL INFECTION

#711
US20250281458A1
Human necessities

DIALKYL TRYPTAMINES AND THEIR THERAPEUTIC USES

#712
US20250281459A1
Human necessities

LIPIDS, FORMULATIONS, AND USES THEREOF

#713
US20250281460A1
Human necessities

PEGYLATED BILIRUBIN FOR THE TREATMENT OF HYPERLIPIDEMIA, OBESITY, FATTY LIVER DISEASE, CARDIOVASCULAR DISEASES AND TYPE II DIABETES

#714
US20250281461A1
Human necessities

USE OF MEBENDAZOLE FOR TREATING VIRAL INFECTION

#715
US20250281462A1
Human necessities

THERAPEUTICALLY EFFECTIVE ORAL ADMINISTRATION OF A 2 ARYLBENZIMIDAZOLE

#716
US20250281463A1
Human necessities

DOSING REGIMEN FOR A SELECTIVE S1P1 RECEPTOR AGONIST

#717
US20250281464A1
Human necessities

TREATMENT OF PATHOGENIC NEISSERIA SP. INFECTION WITH TRIAZOLE ANTIFUNGAL AGENTS

#718
US20250281465A1
Human necessities

MOLECULES THAT ENHANCE EXTRACELLULAR VESICLE RELEASE

#719
US20250281466A1
Human necessities

USE OF CLOPIDOGREL OR COMBINATIONS THEREOF TO TREAT AMYOTROPHIC LATERAL SCLEROSIS, DAMAGES CAUSED BY THE NORMAL AGING PROCESS, NERVE INJURIES, MUSCULAR DYSTROPHY, STRENUOUS PHYSICAL ACTIVITIES AND OTHER CONDITIONS THAT AFFECT SYNAPSES AS WELL AS SKELETAL MUSCLES

#720
US20250281467A1
Human necessities

MODULATORS OF INTRACELLULAR CHLORIDE CONCENTRATION FOR USE IN THE TREATMENT OF COGNITIVE DECLINE

#721
US20250281468A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE AND FUSOBACTERIA-CAUSED OR RELATED DISEASES AND CONDITIONS

#722
US20250281469A1
Human necessities

RIFABUTIN TREATMENT METHODS, USES, AND COMPOSITIONS

#723
US20250281470A1
Human necessities

COMPOSITIONS FOR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS

#724
US20250281471A1
Human necessities

TOPICAL ROFLUMILAST FORMULATION HAVING IMPROVED DELIVERY AND PLASMA HALF- LIFE

#725
US20250281472A1
Human necessities

OPHTHALMIC COMPOSITION INHIBITING OCCURRENCE OF N-OXOPYRIDINE COMPOUND FOR PREVENTING OR TREATING EYE DISEASE

#726
US20250281473A1
Human necessities

CDK Inhibitors And Their Use As Pharmaceuticals

#727
US20250281474A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR TREATING COGNITIVE DECLINE OR FOR TREATING OVERWEIGHTNESS OR OBESITY

#728
US20250281475A1
Human necessities

A PHARMACEUTICAL COMPOSITION OF PITOLISANT HYDROCHLORIDE AND THEIR PROCESS FOR THE PREPARATION

#729
US20250281476A1
Human necessities

EFINACONAZOLE ORAL COMPOSITION

#730
US20250281477A1
Human necessities

TREATMENT OF CNS CONDITIONS

#731
US20250281478A1
Human necessities

METHODS FOR PREVENTING OR TREATING KIDNEY DISEASES

#732
US20250281479A1
Human necessities

TREATMENT OF CAVERNOUS ANGIOMAS WITH A 4-SUBSTITUTED PIPERIDINE DERIVATIVE

#733
US20250281480A1
Human necessities

PHARMACEUTICAL DRY POWDER INHALATION FORMULATION

#734
US20250281481A1
Human necessities

NALTREXONE FOR BOOSTING THE THERAPEUTIC UTILTY OF 5-HT RECEPTOR AGONISTS

#735
US20250281482A1
Human necessities

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES

#736
US20250281483A1
Human necessities

TRANSCRIPTION FACTOR EB ACTIVATORS AND USES THEREOF

#737
US20250281484A1
Human necessities

METHODS OF IMPROVING LUNG FUNCTION

#738
US20250281485A1
Human necessities

DIAGNOSIS AND/OR TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION

#739
US20250281486A1
Human necessities

THERAPEUTIC STRATEGIES TO MANAGE FACIAL CONTRACTURES POST INJURY

#740
US20250281487A1
Human necessities

CDK INHIBITORS

#741
US20250281488A1
Human necessities

VCP INHIBITORS AND USES THEREOF FOR TREATMENT

#742
US20250281489A1
Human necessities

BIOMARKERS FOR PREDICTING SENSITIVITY TO CANCER TREATMENTS

#743
US20250281490A1
Human necessities

RUC-4 FORMULATIONS

#744
US20250281491A1
Human necessities

DUAL FUNCTIONING IMMUNE MODULATING COMPOUNDS, FORMULATIONS, AND USES THEREOF

#745
US20250281492A1
Human necessities

NEW CRYSTALLINE FORMS OF SALT OF 7-CYCLOPENTYL-2-(5-PIPERAZIN-1-YL-PYRIDIN-2-YLAMINO)-7H-PYRROLO[2,3-D]PYRIMIDINE -6-CARBOXYLIC ACID DIMETHYLAMIDE

#746
US20250281493A1
Human necessities

METHODS FOR TREATING CONGENITAL EPIDERMAL HYPERPLASIA AND COMPOSITIONS FOR SAME

#747
US20250281494A1
Human necessities

COMPOSITIONS AND METHODS FOR THEIR PRODUCTION

#748
US20250281495A1
Human necessities

METHODS FOR INHIBITING INFLAMMATION AND PROGRESSION OF ATHEROSCLEROTIC PLAQUES AND CARDIOVASCULAR EVENTS IN PATIENTS WITH CEREBRO- AND CARDIO-VASCULAR DISEASE

#749
US20250281496A1
Human necessities

METHODS OF TREATING NEUROPATHY USING FORETINIB AND COMPOSITIONS THEREOF

#750
US20250281497A1
Human necessities

FUSED AMINO PYRIMIDINE COMPOUNDS FOR TREATMENT OF SEIZURE DISORDERS

#751
US20250281498A1
Human necessities

FUSED AMINO PYRIMIDINE COMPOUNDS FOR TREATMENT OF SYNUCLEINOPATHIES AND TDP-43 PROTEINOPATHIES

#752
US20250281499A1
Human necessities

FUSED AMINO PYRIMIDINE COMPOUNDS FOR TREATMENT OF NEUROPATHIC AND NEURO-INFLAMMATORY PAIN

#753
US20250281500A1
Human necessities

FUSED AMINO PYRIMIDINE COMPOUNDS AND PRIDOPIDINE FOR TREATMENT OF HUNTINGTON’S DISEASE

#754
US20250281501A1
Human necessities

SALTS AND SOLID FORMS OF (S)-3-(4-((4-(MORPHOLINOMETHYL)BENZYL)OXY)-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME

#755
US20250281502A1
Human necessities

NEW DRUG APPLICATION

#756
US20250281503A1
Human necessities

DO3A-BASED ANTITHROMBOTIC AGENT OR HEMOLYTIC AGENT CONTAINING GADOLINIUM COMPLEX

#757
US20250281504A1
Human necessities

Method for improving insulin insensitivity

#758
US20250281505A1
Human necessities

METHODS AND COMPOSITIONS FOR TESTOSTERONE PRODUCTION

#759
US20250281506A1
Human necessities

APPLICATION OF HYDROXYPROGESTERONE CAPROATE IN ENHANCING TUMOR TREATMENT EFFECT

#760
US20250281507A1
Human necessities

METHODS OF TREATING NEPHROTIC SYNDROME

#761
US20250281508A1
Human necessities

CATIONIC STEROIDAL ANTIMICROBIAL SALTS

#762
US20250281509A1
Human necessities

SEQUENTIAL HORMONE THERAPY TO IMPROVE SURVIVAL AND ENHANCE RESPONSE TO IMMUNE THERAPY IN MEN WITH PROSTATE CANCER

#763
US20250281510A1
Human necessities

COMBINED THERAPY OF 4'-THIO-5-AZA-2'-DEOXYCYTIDINE AND VENETOCLAX

#764
US20250281511A1
Human necessities

N-(PHENYLSULFONYL)BENZAMIDES AND RELATED COMPOUNDS AS BCL-2 INHIBITORS

#765
US20250281512A1
Human necessities

BUFFERING AGENT-CONTAINING COMPOSITIONS AND METHODS OF USING SAME

#766
US20250281513A1
Human necessities

USE OF PSYCHEDELICS TO TREAT DEMENTIA

#767
US20250281514A1
Human necessities

TREATMENT OF CANCER PATIENTS HAVING KRAS MUTATIONS

#768
US20250281515A1
Human necessities

CARBORANE COMPOUNDS, CARBORANE ANALOGS, AND METHODS OF USE THEREOF

#769
US20250281516A1
Human necessities

NUTRACEUTICAL FORMULATION FOR POLYCYSTIC OVARY SYNDROME

#770
US20250281517A1
Human necessities

SENOLYSIS BY AMMONIA-LOWERING COMPONENT

#771
US20250281518A1
Human necessities

METHODS AND AGENTS FOR PREVENTING SKELETAL AGING, OSTEOPOROSIS AND OBESITY

#772
US20250281519A1
Human necessities

NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS, COMBINATIONS AND USES RELATED THERETO

#773
US20250281520A1
Human necessities

ADVANTAGEOUS ANTI-HCV COMBINATION THERAPY

#774
US20250281521A1
Human necessities

COMPOSITIONS FOR THE TREATMENT OF DRY EYE

#775
US20250281522A1
Human necessities

HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS

#776
US20250281523A1
Human necessities

SULFATED GLYCOSAMINOGLYCAN COMPOUNDS, METHODS, AND USES THEREOF

#777
US20250281524A1
Human necessities

THERAPY OF HIGH-RISK HUMAN PAPILLOMAVIRUS INFECTIONS

#778
US20250281525A1
Human necessities

CALCIUM OR MAGNESIUM CHLORIDE SALT-BASED COMPOSITION

#779
US20250281526A1
Human necessities

Compositions Comprising Stable Free Available Chlorine Species and Peroxides, Methods of Making and Uses Thereof

#780
US20250281527A1
Human necessities

COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER CELLS BY INDUCTION OF CYTOTOXIC OXIDATIVE STRESS

#781
US20250281528A1
Human necessities

GRAPHENE OXIDE-CATIONIC SILVER NANOCOMPOSITES AND THEIR USE AS BROAD-SPECTRUM ANTIMICROBIAL AGENTS

#782
US20250281529A1
Human necessities

TREATMENT OF DISEASES AND CONDITIONS OF THE EYE

#783
US20250281530A1
Human necessities

METHODS OF PREPARING COHN POOL CONCENTRATE FROM BLOOD PLASMA THROUGH ULTRAFILTRATION

#784
US20250281531A1
Human necessities

METHODS AND COMPOSITIONS FOR DETOXIFICATION OF CHRONIC EXPOSURE TO TOXINS

#785
US20250281532A1
Human necessities

METHODS FOR DIAGNOSING OR TREATING HEALTH CONDITIONS OR OPTIMIZING THERAPEUTIC EFFICACY OF CAR-T CELLS THERAPIES

#786
US20250281533A1
Human necessities

POLYPEPTIDE SPECIFIC FOR MUCIN 1 AND USE THEREOF

#787
US20250281534A1
Human necessities

METHODS AND COMPOSITIONS FOR IMPROVING IMMUNOTHERAPY

#788
US20250281535A1
Human necessities

ANTI-HUMAN CD45RC BINDING DOMAINS AND USES THEREOF

#789
US20250281536A1
Human necessities

CD4-SPECIFIC ANTIBODY CONSTRUCTS AND COMPOSITIONS AND USES THEREOF

#790
US20250281537A1
Human necessities

TREATMENT OF CANCER PATIENTS WITH TUMOR INFILTRATING LYMPHOCYTE THERAPIES IN COMBINATION WITH AN IL-15R AGONIST

#791
US20250281538A1
Human necessities

COMPOSITIONS TARGETING GPC2 AND GPC3 AND THEIR USE FOR TREATING SOLID TUMORS

#792
US20250281539A1
Human necessities

METHODS OF CULTURING TUMOR INFILTRATING LYMPHOCYTES

#793
US20250281540A1
Human necessities

Methods for Haematopoietic Stem Cell Transplantation

#794
US20250281541A1
Human necessities

COMPOSITION FOR WOUND TREATMENT COMPRISING STEM CELL-DERIVED EXTRACELLULAR VESICLES WITH ENHANCED EFFICACY

#795
US20250281542A1
Human necessities

MESENCHYMAL STEM CELLS FOR ORAL INFLAMMATION TREATMENT

#796
US20250281543A1
Human necessities

PREVENTION OF AUTOIMMUNE DIABETES

#797
US20250281544A1
Human necessities

GENE THERAPY FOR BLEEDING DISORDERS

#798
US20250281545A1
Human necessities

Human Adipose-Derived Stem Cell Exosomes And Their Packaging For Use At Room Temperature

#799
US20250281546A1
Human necessities

Multi-Nutrient Delivery Composition

#800
US20250281547A1
Human necessities

Fish Oil Traditional Chinese Medicine Complex with Comprehensive Blood Lipid Regulating Effect and Preparation Method and Application thereof

#801
US20250281548A1
Human necessities

ANTIMICROBIAL COMPOSITIONS COMPRISING EXTRACELLULAR VESICLES AND METHODS THEREOF

#802
US20250281549A1
Human necessities

PROPHYLACTIC OR THERAPEUTIC COMPOSITION FOR GRAFT-VERSUS-HOST DISEASE

#803
US20250281550A1
Human necessities

COMPOSITIONS AND METHODS FOR IMPROVING MITOCHONDRIAL FUNCTION

#804
US20250281551A1
Human necessities

AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF PULMONARY HYPERTENSION

#805
US20250281552A1
Human necessities

AIRWAY MEDICAMENTS

#806
US20250281553A1
Human necessities

BACTERIOPHAGE THERAPY AGAINST ADHERENT-INVASIVE ESCHERICHIA COLI

#807
US20250281554A1
Human necessities

COMPOSITION FOR IMPROVING DRUG SENSITIVITY OF ANTIBACTERIAL DRUG TO METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA), COMPOSITION FOR TREATING OR PREVENTING MRSA INFECTION, AND COMPOSITION FOR REDUCING VIRULENCE OF MRSA

#808
US20250281555A1
Human necessities

BACTERIOPHAGE COMPOSITIONS AND METHODS FOR TREATMENT OF BACTERIAL INFECTIONS

#809
US20250281556A1
Human necessities

PRODUCTION OF RNA POLYNUCLEOTIDES ENCODING PICORNAVIRUS

#810
US20250281557A1
Human necessities

METHODS FOR CASCADE AMPLIFICATIONS OF THERAPEUTIC PAYLOADS (CATP) & COMPOSITIONS FOR CANCER IMMUNOTHERAPIES AND GENE THERAPY

#811
US20250281558A1
Human necessities

Composition and Method for Treating Colic in Infants

#812
US20250281559A1
Human necessities

DRUG FOR TREATMENT OF BREAST CANCER WITH ANTLER AND GINSENG AS SOVEREIGN DRUG AND PREPARATION METHOD AND APPLICATION THEREOF

#813
US20250281560A1
Human necessities

METHOD FOR PREVENTING AND/OR TREATING CANCER OR AUTOIMMUNE DISEASE WITH 3,4,2 Prime,3 Prime,4 Prime-PENTAHYDROXY-TRANS-CHALCONE

#814
US20250281561A1
Human necessities

APPLICATION OF LYCIUM BARBARUM LEAF EXTRACT IN PREPARING DRUG FOR TREATING DIABETIC RETINOPATHY

#815
US20250281562A1
Human necessities

METHOD AND COMPOSITION FOR IMPROVING MUSCLE PERFORMANCE

#816
US20250281563A1
Human necessities

COMPOSITIONS AND METHODS FOR HAIR TREATMENT

#817
US20250281564A1
Human necessities

DYSREGULATION OF NEUROPROTEASOMES BY APOE ISOFORMS DRIVES ENDOGENOUS TAU AGGREGATION

#818
US20250281565A1
Human necessities

PROBIOTIC BACTERIAL MOLECULES AND THEIR USE IN METHODS TO TREAT/PREVENT INFECTION BY HARMFUL BACTERIA AND TO PROVIDE NUTRITIONAL HEALTH

#819
US20250281566A1
Human necessities

EXTENDED-RELEASE INJECTABLE GEL FORMULATIONS CONTAINING ANGIOTENSIN-(1-7) OLIGOPEPTIDES OR VARIANTS THEREOF

#820
US20250281567A1
Human necessities

DESMOPRESSIN ORAL COMPOSITIONS

#821
US20250281568A1
Human necessities

METHOD FOR TREATING OR PREVENTING DRUG-INDUCED LIVER INJURY WITH PEPTIDE COMPOSITION

#822
US20250281569A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING NEUROENDOCRINE TUMORS

#823
US20250281570A1
Human necessities

Treatment of Myasthenia Gravis with Zilucoplan

#824
US20250281571A1
Human necessities

THERAPEUTIC DRUG FOR MYOTONIC DYSTROPHY TYPE 1

#825
US20250281572A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING METABOLIC DISORDERS

#826
US20250281573A1
Human necessities

Methods of Treating Retinal Degenerative Diseases Using AIMP2-DX2 and Optionally a Target Sequence for miR-142 and Compositions Thereof

#827
US20250281574A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING COMPLICATIONS OF VIRAL INFECTIONS AND OTHER RESPIRATORY DISORDERS

#828
US20250281575A1
Human necessities

METHODS FOR THE TREATMENT OF DIABETES-ASSOCIATED AUTONOMIC NEUROPATHY

#829
US20250281576A1
Human necessities

PROPHYLACTIC ADMINISTRATION METHOD AGAINST RESPIRATORY VIRUS, COMPRISING ADMINISTERING INTERFERON-BETA TO POTENTIAL RESPIRATORY VIRUS-INFECTED SUBJECT

#830
US20250281577A1
Human necessities

USE OF GLP-1 RECEPTOR AGONISTS TO TREAT IMPULSE-CONTROL DISORDERS

#831
US20250281578A1
Human necessities

METHODS OF USING A GIP/GLP1 CO-AGONIST FOR THERAPY

#832
US20250281579A1
Human necessities

Methods and Compositions for Oral Administration of Proteins

#833
US20250281580A1
Human necessities

COMPOSITIONS, METHODS AND USES FOR TREATING CYSTIC FIBROSIS AND RELATED DISORDERS

#834
US20250281581A1
Human necessities

METHODS OF CANCER TREATMENT BY INTRATUMORAL INJECTION OF MUTANT COLLAGENASE

#835
US20250281582A1
Human necessities

TREATMENT OF PRURITUS IN HORSES

#836
US20250281583A1
Human necessities

COMPOSITION OF MRNA-ENCODED IL15 FUSION PROTEINS AND METHODS OF USE THEREOF

#837
US20250281584A1
Human necessities

ACTIVE VACCINATION FOR THE TREATMENT OF NGF-RELATED DISORDERS

#838
US20250281585A1
Human necessities

VETERINARY COMPOSITIONS OF MODIFIED VIRUS-LIKE PARTICLES OF CMV AND IL-1 BETA MUTEIN ANTIGENS

#839
US20250281586A1
Human necessities

VETERINARY COMPOSITIONS OF MODIFIED VIRUS-LIKE PARTICLES OF CMV AND CANINE IL-1 BETA MUTEIN ANTIGENS

#840
US20250281587A1
Human necessities

VETERINARY COMPOSITIONS OF MODIFIED VIRUS-LIKE PARTICLES OF CMV AND FELINE IL-1 BETA MUTEIN ANTIGENS

#841
US20250281588A1
Human necessities

PREVENTION AND TREATMENT OF INFECTIONS WITH INTRACELLULAR BACTERIA

#842
US20250281589A1
Human necessities

COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE PROTECTIVE AGAINST LYME DISEASE

#843
US20250281590A1
Human necessities

IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED ESCHERICHIA COLI SACCHARIDES AND USES THEREOF

#844
US20250281591A1
Human necessities

STAPHYLOCOCCUS AUREUS VACCINE COMPOSITIONS

#845
US20250281592A1
Human necessities

IMMUNOGENIC COMPOSITION WITH PROTEIN MICRO- AND NANOPARTICLES

#846
US20250281593A1
Human necessities

Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C virus

#847
US20250281594A1
Human necessities

TRUNCATED RECOMBINANT L1 PROTEIN OF HUMAN PAPILLOMAVIRUS

#848
US20250281595A1
Human necessities

NOVEL INFLUENZA ANTIGENS

#849
US20250281596A1
Human necessities

IONIZABLE CATIONIC COMPOUND

#850
US20250281597A1
Human necessities

A VACCINE FOR THE PROTECTION OF PIGLETS AGAINST SWINE INFLUENZA A VIRUS INFECTION

#851
US20250281598A1
Human necessities

DNA DISPLAY OF FOLDED RNA LIBRARIES ENABLING RNA-SELEX WITHOUT REVERSE TRANSCRIPTION

#852
US20250281599A1
Human necessities

COMPOSITION COMPRISING ENGINEERED PLANT-DERIVED EXTRACELLULAR VESICLES AND USE THEREOF AS A VACCINE

#853
US20250281600A1
Human necessities

NOVEL COMPOSITIONS OF MATTER COMPRISING STABILIZED CORONAVIRUS ANTIGENS AND THEIR USE

#854
US20250281601A1
Human necessities

VACCINATION AGAINST BACTERIAL AND BETACORONAVIRUS INFECTIONS

#855
US20250281602A1
Human necessities

Replicon Compositions and Methods of Using Same for the Treatment of Diseases

#856
US20250281603A1
Human necessities

Compositions for the Treatment of Infectious Disease Related Complications and Methods Thereof

#857
US20250281604A1
Human necessities

mRNA vaccine for porcine Deltacoronavirus, preparation method and application thereof

#858
US20250281605A1
Human necessities

Antigenic Epstein Barr Virus Polypeptides

#859
US20250281606A1
Human necessities

CANNABIDIOL FOR AUGMENTING VACCINE MEDIATED IMMUNITY AND PROPHYLAXIS OF COVID-19

#860
US20250281607A1
Human necessities

MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER

#861
US20250281608A1
Human necessities

STABLE FORMULATIONS FOR TNF-alpha ANTIBODIES AND USES THEREOF

#862
US20250281609A1
Human necessities

COMPOSITION FOR TREATING OR PREVENTING CANCER

#863
US20250281610A1
Human necessities

P2RY2 ACTIVITY MODULATORS

#864
US20250281611A1
Human necessities

NOVEL CELL THERAPY SYSTEM

#865
US20250281612A1
Human necessities

CD27-EXTRACELLULAR DOMAIN CAR TO TARGET CD70-POSITIVE TUMORS

#866
US20250281613A1
Human necessities

ENHANCING SAFETY OF T-CELL-MEDIATED IMMUNOTHERAPY

#867
US20250281614A1
Human necessities

CHIMERIC RECEPTORS COMPRISING INTERLEUKIN 7 RECEPTOR (IL7R) DOMAINS

#868
US20250281615A1
Human necessities

SYSTEMS AND METHODS FOR TREATING CANCERS OF THE SKIN

#869
US20250281616A1
Human necessities

METHODS FOR TREATING NEOPLASTIC DISEASES

#870
US20250281617A1
Human necessities

Drug Delivery System

#871
US20250281618A1
Human necessities

PROCESS FOR REDUCING SUBVISIBLE PARTICLES IN A PHARMACEUTICAL FORMULATION

#872
US20250281619A1
Human necessities

DOCETAXEL-ACONITIC ANHYDRIDE CONJUGATE EXHIBITING ANTI-TUMOR ACTIVITY WITHOUT IN VIVO TOXICITY

#873
US20250281620A1
Human necessities

HYDROXYBISPHOSPHONIC DERIVATIVES OF MELOXICAM FOR THE TREATMENT OF INFLAMMATORY JOINT DISEASES

#874
US20250281621A1
Human necessities

GPC3 APTAMERS AND VARIANTS AND USE THEREOF

#875
US20250281622A1
Human necessities

FN3 DOMAIN-siRNA CONJUGATES AND USES THEREOF

#876
US20250281623A1
Human necessities

HETEROBIFUNCTIONAL COMPOUNDS AND THEIR USE IN TREATING DISEASE

#877
US20250281624A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING CHRONIC INFLAMMATORY INJURY, METAPLASIA, DYSPLASIA AND CANCERS OF EPITHELIAL TISSUES

#878
US20250281625A1
Human necessities

FOLIC ACID-CONJUGATED AMINOCLAY BASED NANOCOMPOSITES FOR THE SITE-SPECIFIC DRUG DELIVERY, METHOD FOR THEIR PREPARATION AND THEIR USE

#879
US20250281626A1
Human necessities

MANNOSE 3 GLYCAN-MEDIATED PROTEIN DEGRADATION

#880
US20250281627A1
Human necessities

CANCER-TARGETING PEPTIDE, PRODRUG NANOPARTICLES COMPRISING SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR CANCER PREVENTION OR TREATMENT

#881
US20250281628A1
Human necessities

COMPOSITE NANOPARTICULATE MINERALIZED COLLAGEN GLYCOSAMINOGLYCAN MATERIALS WITH TIME RELEASE ANTI-RESORPTIVE FACTORS

#882
US20250281629A1
Human necessities

COMPOSITIONS AND METHODS FOR ANTI-PHOSPHOCHOLINE ACTIVE IMMUNOTHERAPY

#883
US20250281630A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND/OR PREVENTION

#884
US20250281631A1
Human necessities

ANTIBODY-DRUG CONJUGATES AND PREPARATION METHODS AND USE THEREOF

#885
US20250281632A1
Human necessities

LGALS3BP ANTIBODY-DRUG-CONJUGATE AND ITS USE FOR THE TREATMENT OF CANCER

#886
US20250281633A1
Human necessities

HER2 TARGETING FC ANTIGEN BINDING FRAGMENT-DRUG CONJUGATES

#887
US20250281634A1
Human necessities

CONJUGATES COMPRISING A PHOSPHORUS (V) AND A DRUG MOIETY

#888
US20250281635A1
Human necessities

EXTRACELLULAR VESICLE COMPOSITES AND THEIR USES IN THE TREATMENT OF LIVER INJURY

#889
US20250281636A1
Human necessities

CHEMICALLY AND PHOTOCHEMICALLY INITIATED CELL MEMBRANE BLEBBING TO INDUCE CELL VESICLE PRODUCTION, MODIFICATIONS THEREOF, AND USES THEREOF

#890
US20250281637A1
Human necessities

AU, AG AND RICH PHYTOCHEMICAL PAYLOAD NANOMATERIALS, ANTIVIRAL/ANTIBACTERIAL PRODUCTS AND SYNTHESIS METHODS

#891
US20250281638A1
Human necessities

Compositions and Methods for Activating Natural Killer Cells

#892
US20250281639A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING CHRONIC PAIN AND FOR RETROGRADE TRANSDUCTION OF NEURONS

#893
US20250281640A1
Human necessities

NUCLEIC ACID HAVING PROMOTER ACTIVITY AND USE THEREOF

#894
US20250281641A1
Human necessities

VECTORS FOR DELIVERY OF HUMAN GROWTH HORMONE GENE AND MULTIPLE THERAPEUTIC GENES INTO CENTRAL NERVOUS SYSTEM BY CROSSING BLOOD BRAIN BARRIER

#895
US20250281642A1
Human necessities

POLYNUCLEOTIDE FOR TREATMENT OF NEURODEGENERATIVE DISEASE, VECTOR, CELL, PHARMACEUTICAL COMPOSITION, AND SCREENING METHOD

#896
US20250281643A1
Human necessities

SELECTED AAV COMPOSITIONS HAVING PREFERRED BRAIN ENRICHMENT

#897
US20250281644A1
Human necessities

LENTIVIRAL VECTORS AND USES THEREOF

#898
US20250281645A1
Human necessities

Lentiviral Vector

#899
US20250281646A1
Human necessities

PLASMID DNA CONSTRUCTS FOR THERAPEUTIC PROTEIN EXPRESSION

#900
US20250281647A1
Human necessities

STEALTH LIPID NANOPARTICLE COMPOSITIONS FOR CELL TARGETING